Absence of KLF6 gene mutations in human astrocytic tumors and cell lines [2]

International Journal of Cancer

Volumn 111, Issue 4, 2004, Pages 642-643

  Koivisto, Pasi A ^a   Zhang, Xiaohui ^b   Sallinen, Satu Leena ^a   Sallinen, Pauli ^a   Helin, Heikki J ^a   Dong, Jin Tang ^b   Van Meir, Erwin G ^b   Haapasalo, Hannu ^a   Hyytinen, Eija Riitta ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; KRUPPEL LIKE FACTOR 6; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ASTROCYTOMA; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA ISOLATION; DNA SEQUENCE; GENE; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KLF6 GENE; LETTER; MAJOR CLINICAL STUDY; MONOSOMY; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ARTIFACTS; ASTROCYTOMA; BRAIN NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; TUMOR CELLS, CULTURED; ZINC FINGERS;

EID: 3843058209     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20301     Document Type: Letter

References (21)

1. Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH, Bigner DD. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 1988;48:405-11.
2. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988;48:5546-51.
3. Fults D, Pedone CA, Thomas GA, White R. Allelotype of human malignant astrocytoma. Cancer Res 1990;50:5784-9.
4. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A, Speicher MR, Nurnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, et al. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal Gains and losses. Am J Pathol 1994;144:1203-18.
5. Kimmelman AC, Ross DA, Liang BC. Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 1996;34:250-4.
6. Voesten AM, Bijleveld EH, Westerveld A, Hulsebos J. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma. Genes Chromosomes Cancer 1997;20:167-72.
7. Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 1998;22:9-15.
8. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjold M, Larsson C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 1993;92:169-74.
9. Sonoda Y, Murakami Y, TominaGa T, Kayama T, Yoshimoto T, Sekiya T. Deletion mapping of chromosome 10 in human glioma. Jpn J Cancer Res 1996;87:363-7.
10. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. PTEN gene mutations are seen in high-grade but not in low-grade gliomas Cancer Res 1997;57:4187-90.
11. Steck PA, Ligon AH, Cheong P, Yung WK, Pershouse MA. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer 1995;12:255-61.
12. Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiyu T, Murakami Y. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas. Oncogene 1998;16:257-63.
13. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA, et al. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 2001;294:2563-6.
14. Chen C, Hyytinen E-R, Sun X, Helin HJ, Koivisto PA, Frierson HF Jr, Vassella R, Dong J-T. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 2003;162:1349-54.
15. Jeng YM, Hsu HC. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 2003;105:625-9.
16. Kleihues P, Davis R, Oghaki H, Buerger P, Westphal M, Cavenee WK. Pathology and genetics of tumours of the nervous system. International classification of tumours. Lyon, IARC Press, 2000. 22-39.
17. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 1999;9:469-79.
18. Haapala K, Hyytinen E-R, Roiha M, Laurila M, Rantala I, Helin HJ, Koivisto PA. Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide. Lab Invest 2001;81:1647-51.
19. Mühlbauer KR, Grone HJ, Ernst T, Grone E, Tschada R, Hergenhahn M, Hollstein M. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. Br J Cancer 2003;89:687-90.
20. Narla G, Friedman SL, Martignetti JA. Kruppel cripples prostate cancer. KLF6 progress and prospects. Am J Pathol 2003;162:1047-52.
21. Williams C, Ponten F, Moberg C, Söerkvist P, Uhlen M, Ponten J, Sitbon G, Lundeberg J. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 1999;155:1467-71.